首页> 外文期刊>Surgical Endoscopy >Validation of the application of the Japanese curative criteria for superficial adenocarcinoma at the esophagogastric junction treated by endoscopic submucosal dissection: a long-term analysis.
【24h】

Validation of the application of the Japanese curative criteria for superficial adenocarcinoma at the esophagogastric junction treated by endoscopic submucosal dissection: a long-term analysis.

机译:内镜下黏膜下剥离治疗食管胃交界处浅表腺癌的日本治愈标准的应用验证:一项长期分析。

获取原文
获取原文并翻译 | 示例
           

摘要

A few studies have shown promising results with endoscopic submucosal dissection (ESD) for adenocarcinoma at the esophagogastric junction (EGJAC). However, curative criteria on the histology of EGJAC have not been developed, and long-term clinical results are lacking. The purpose of this study was to validate the application of the Japanese curative criteria to EGJAC after ESD.Between September 2002 and March 2009, 1,350 superficial gastric neoplasms in 1,181 patients were treated by ESD at a single tertiary cancer center. For this retrospective cohort study, 49 patients with 50 superficial EGJACs were extracted from our database. Complications, en bloc resection rate, curative resection rate, overall survival, and cause-specific survival were evaluated in all patients. For assessment of curability, curative criteria proposed by the Japanese Gastric Cancer Association for early gastric carcinoma after endoscopic resection were used.Delayed bleeding and postoperative stenosis each occurred in three (6 %) patients but were managed endoscopically. No other major complications were observed related to ESD. The en bloc resection rate was 98 % (49/50), and the curative resection rate was 72 % (36/50). With a median follow-up period of 47 (range 22-97) months, the overall survival rates and cause-specific survival rates at 5 years were 86.2 % [95 % confidence interval (CI) 76-97] and 100 % (95 % CI 91-100), respectively.Endoscopic submucosal dissection with application of the Japanese curative criteria may be a feasible and effective treatment for curative intent in patients with superficial EGJAC.
机译:几项研究表明,对于食管胃交界处的腺癌(EGJAC),内镜黏膜下剥离术(ESD)可取得令人鼓舞的结果。然而,关于EGJAC的组织学的治疗标准尚未建立,并且缺乏长期的临床结果。本研究的目的是验证ESD术后日本根治性标准对EGJAC的适用性.2002年9月至2009年3月,在单个三级癌症中心接受ESD治疗的1,181例患者中有1,350例浅表胃肿瘤。在这项回顾性队列研究中,从我们的数据库中提取了49例50例浅表EGJAC患者。对所有患者的并发症,整体切除率,治愈性切除率,总生存率和特定原因生存率进行了评估。为评估可治愈性,使用了日本胃癌协会提出的内镜切除术后早期胃癌的治愈标准,其中3例(6%)患者发生了延迟出血和术后狭窄,但均采用内镜治疗。没有观察到与ESD相关的其他主要并发症。整体切除率为98%(49/50),治愈率为72%(36/50)。中位随访期为47(22-97)个月,在5年时的总生存率和特定原因生存率分别为86.2%[95%置信区间(CI)76-97]和100%(95 %CI 91-100)。应用日本治愈标准的内镜下黏膜下剥离术可能是治疗浅表EGJAC患者治愈意图的一种可行而有效的治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号